Additionally, a better understanding is required of NfL dynamics and turnover (e.g. the potential role of microglia in NfL clearance) and the relationship between NfL and comorbidities such as subclinical brain injuries, cardiovascular events, diabetes, and prescribed medication use, which can all increase blood-based NfL levels.9,10. This evidence concerns the gene NEFL and brain injury.